Ambea AB (publ) (STO:AMBEA)
126.40
-1.40 (-1.10%)
Mar 25, 2026, 3:19 PM CET
Ambea AB Market Cap
Ambea AB has a market cap or net worth of 10.49 billion as of March 25, 2026. Its market cap has increased by 18.61% in one year.
Market Cap
10.49B
Enterprise Value
23.00B
Revenue
16.04B
Ranking
n/a
PE Ratio
16.14
Stock Price
126.40
Market Cap Chart
Since March 31, 2017, Ambea AB's market cap has increased from 5.58B to 10.49B, an increase of 88.09%. That is a compound annual growth rate of 7.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 10.49B | -11.71% |
| Dec 30, 2025 | 11.88B | 46.78% |
| Dec 30, 2024 | 8.10B | 71.86% |
| Dec 29, 2023 | 4.71B | 13.21% |
| Dec 30, 2022 | 4.16B | -27.18% |
| Dec 30, 2021 | 5.71B | -7.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 124.44B |
| Getinge AB | 49.58B |
| Sectra AB | 42.43B |
| Medicover AB | 27.78B |
| Vimian Group AB | 13.25B |
| Nolato AB | 12.75B |
| Vitrolife AB | 12.05B |
| Bonesupport Holding AB | 11.92B |